MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
164 hedge funds and large institutions have $1.21B invested in Momenta Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 82 increasing their positions, 41 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 162 → 164 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
164
Holding in Top 10
1
Calls
$3.33M
Puts
$373K
Top Buyers
| 1 | +$84.4M | |
| 2 | +$13.9M | |
| 3 | +$10.6M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.98M |
| 5 |
Renaissance Technologies
New York
|
+$8.77M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$15.1M | |
| 3 | -$5.94M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$5.75M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$4.18M |